These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35166678)

  • 1. Web-Based Tool (FH Family Share) to Increase Uptake of Cascade Testing for Familial Hypercholesterolemia: Development and Evaluation.
    Bangash H; Makkawy A; Gundelach JH; Miller AA; Jacobson KA; Kullo IJ
    JMIR Hum Factors; 2022 Feb; 9(1):e32568. PubMed ID: 35166678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing and Optimizing Innovative Tools to Address Familial Hypercholesterolemia Underdiagnosis: Identification Methods, Patient Activation, and Cascade Testing for Familial Hypercholesterolemia.
    Campbell-Salome G; Jones LK; Masnick MF; Walton NA; Ahmed CD; Buchanan AH; Brangan A; Esplin ED; Kann DG; Ladd IG; Kelly MA; Kindt I; Kirchner HL; McGowan MP; McMinn MN; Morales A; Myers KD; Oetjens MT; Rahm AK; Schmidlen TJ; Sheldon A; Simmons E; Snir M; Strande NT; Walters NL; Wilemon K; Williams MS; Gidding SS; Sturm AC
    Circ Genom Precis Med; 2021 Feb; 14(1):e003120. PubMed ID: 33480803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motivating cascade testing for familial hypercholesterolemia: applying the extended parallel process model for clinician communication.
    Campbell-Salome G; Walters NL; Ladd IG; Sheldon A; Ahmed CD; Brangan A; McMinn MN; Rahm AK; Schwartz MLB; Tricou E; Fisher CL; Sturm AC
    Transl Behav Med; 2022 Jul; 12(7):800-809. PubMed ID: 35429393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innovative Implementation Strategies for Familial Hypercholesterolemia Cascade Testing: The Impact of Genetic Counseling.
    Morgan KM; Campbell-Salome G; Walters NL; Betts MN; Brangan A; Johns A; Kirchner HL; Lindsey-Mills Z; McGowan MP; Tricou EP; Rahm AK; Sturm AC; Jones LK
    J Pers Med; 2024 Aug; 14(8):. PubMed ID: 39202032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Implementation Science Framework to Develop a Clinical Decision Support Tool for Familial Hypercholesterolemia.
    Bangash H; Pencille L; Gundelach JH; Makkawy A; Sutton J; Makkawy L; Dikilitas O; Kopecky S; Freimuth R; Caraballo PJ; Kullo IJ
    J Pers Med; 2020 Jul; 10(3):. PubMed ID: 32717811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. User and Usability Testing of a Web-Based Genetics Education Tool for Parkinson Disease: Mixed Methods Study.
    Han N; Paul RA; Bardakjian T; Kargilis D; Bradbury AR; Chen-Plotkin A; Tropea TF
    JMIR Bioinform Biotechnol; 2023 Aug; 4():e45370. PubMed ID: 38935961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia.
    Campbell-Salome G; Jones LK; Walters NL; Morgan KM; Brangan A; Ladd IG; McGowan MP; Wilemon K; Schmidlen TJ; Simmons E; Schwartz MLB; McMinn MN; Tricou E; Rahm AK; Ahmed CD; Sturm AC
    BMC Health Serv Res; 2023 Apr; 23(1):340. PubMed ID: 37020233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Family cascade screening for equitable identification of familial hypercholesterolemia: study protocol for a hybrid effectiveness-implementation type III randomized controlled trial.
    Johnson C; Chen J; McGowan MP; Tricou E; Card M; Pettit AR; Klaiman T; Rader DJ; Volpp KG; Beidas RS
    Implement Sci; 2024 Apr; 19(1):30. PubMed ID: 38594685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives from individuals with familial hypercholesterolemia on direct contact in cascade screening.
    Schwiter R; Brown E; Murray B; Kindt I; Van Enkevort E; Pollin TI; Sturm AC
    J Genet Couns; 2020 Dec; 29(6):1142-1150. PubMed ID: 32223038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing Premature Coronary Artery Disease in Malaysia by Early Identification of Familial Hypercholesterolemia Using the Familial Hypercholesterolemia Case Ascertainment Tool (FAMCAT): Protocol for a Mixed Methods Evaluation Study.
    Ramli AS; Qureshi N; Abdul-Hamid H; Kamal A; Kanchau JD; Shahuri NS; Akyea RK; Silva L; Condon L; Abdul-Razak S; Al-Khateeb A; Chua YA; Mohamed-Yassin MS; Baharudin N; Badlishah-Sham SF; Abdul Aziz AF; Mohd Kasim NA; Sheikh Abdul Kadir SH; Kai J; Leonardi-Bee J; Nawawi H
    JMIR Res Protoc; 2023 Jun; 12():e47911. PubMed ID: 37137823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Web-Based Cancer Self-Management Program (I-Can Manage) Targeting Treatment Toxicities and Health Behaviors: Human-Centered Co-design Approach and Cognitive Think-Aloud Usability Testing.
    Howell D; Bryant Lukosius D; Avery J; Santaguida A; Powis M; Papadakos T; Addario V; Lovas M; Kukreti V; Haase K; Mayo SJ; Papadakos J; Moradian S; Krzyzanowska MK
    JMIR Cancer; 2023 Jul; 9():e44914. PubMed ID: 37477968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parents' User Experience Accessing and Using a Web-Based Map of COVID-19 Recommendations for Health Decision-Making: Qualitative Descriptive Study.
    Cyrkot S; Hartling L; Scott SD; Elliott SA
    JMIR Form Res; 2024 Mar; 8():e53593. PubMed ID: 38506915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient and Provider Perspectives on a Decision Aid for Familial Hypercholesterolemia.
    Farwati M; Kumbamu A; Kochan DC; Kullo IJ
    J Pers Med; 2018 Nov; 8(4):. PubMed ID: 30400379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proof-of-concept study of cascade screening for Familial Hypercholesterolemia in the US, adapted from the Dutch model.
    McGowan MP; Cuchel M; Ahmed CD; Khera A; Weintraub WS; Wilemon KA; Ahmad Z
    Am J Prev Cardiol; 2021 Jun; 6():100170. PubMed ID: 34327496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.
    O'Brien EC; Roe MT; Fraulo ES; Peterson ED; Ballantyne CM; Genest J; Gidding SS; Hammond E; Hemphill LC; Hudgins LC; Kindt I; Moriarty PM; Ross J; Underberg JA; Watson K; Pickhardt D; Rader DJ; Wilemon K; Knowles JW
    Am Heart J; 2014 Mar; 167(3):342-349.e17. PubMed ID: 24576518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Testing for Familial Hypercholesterolemia: Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2022; 22(3):1-155. PubMed ID: 36158868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and initial testing of a multi-stakeholder intervention for Lynch syndrome cascade screening: an intervention mapping approach.
    Passero L; Srinivasan S; Grewe ME; Leeman J; Berg J; Reuland D; Roberts MC
    BMC Health Serv Res; 2022 Nov; 22(1):1411. PubMed ID: 36434579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceptability, Appropriateness, and Feasibility of Automated Screening Approaches and Family Communication Methods for Identification of Familial Hypercholesterolemia: Stakeholder Engagement Results from the IMPACT-FH Study.
    Jones LK; Walters N; Brangan A; Ahmed CD; Gatusky M; Campbell-Salome G; Ladd IG; Sheldon A; Gidding SS; McGowan MP; Rahm AK; Sturm AC
    J Pers Med; 2021 Jun; 11(6):. PubMed ID: 34205662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia.
    Ellis KL; Pérez de Isla L; Alonso R; Fuentes F; Watts GF; Mata P
    J Am Coll Cardiol; 2019 Mar; 73(9):1029-1039. PubMed ID: 30846097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient acceptance of genetic testing for familial hypercholesterolemia in the CASCADE FH Registry.
    Gidding SS; Sheldon A; Neben CL; Williams HE; Law S; Zhou AY; Wilemon K; Ahmed CD; Kindt I
    J Clin Lipidol; 2020; 14(2):218-223.e2. PubMed ID: 32143996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.